Fig. 9.
Influence of creatinine clearance on exposure of a tMPA, b fMPA, c tMPAG and d fMPAG for patients cotreated with CsA (light) or tacrolimus (dark). AUCs are presented as mean and 95% confidence interval of 50 simulated patients
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.